Krankheitsbezogene Ängste und Depressivität bei COPD-Patienten

Zusammenfassung

Ziel der vorliegenden Studie ist die Analyse von krankheitsbezogenen Ängsten im Zusammenhang mit Depressivität bei COPD-Patienten. Sowohl Angst als auch Depressivität sind ein häufiges komorbides Phänomen bei COPD. Beides kann einen erheblichen Einfluss auf den Verlauf und das Erleben der Erkrankung haben. Bislang wurden in Studien lediglich allgemeine – nicht aber COPD-assoziierte – Ängste erfasst. An der Studie nahmen insgesamt 96 COPD-Patienten (GOLD III/IV) teil. Die MANOVA ergab, dass COPD-Patienten mit auffälligen Depressivitätswerten stärkere krankheitsbezogene Ängste berichten als Patienten mit unauffälligen Depressivitätswerten. Sie leiden unter größerer Angst vor sozialer Ausgrenzung, Angst vor Dyspnoe, Angst vor körperlicher Aktivität und Progredienzangst. Es ergaben sich keine Unterschiede zwischen den beiden Vergleichsgruppen in den medizinisch-objektiven Parametern (FEV ₁ % des Solls; 6-Minuten-Gehtest). Insgesamt belegt unsere Studie die hohe Relevanz der Erfassung krankheitsspezifischer Ängste bei COPD-Patienten im Zusammenhang mit Depressivität. Die rechtzeitige Identifikation und angemessene Behandlung von COPD-bezogenen Ängsten und Depressivität hat eine große Bedeutung für den Krankheitsverlauf.

Abstract

The aim of the present study was to analyze the associations between COPD-specific anxiety and depressive symptoms in COPD patients. Anxiety, as well as depression, is a prevalent comorbid complication in COPD. Either can have a negative impact on patientsʼ experience and the course of disease. So far, assessment in studies has exclusively focused on anxiety in general and not on disease-related fears. The present study comprised a sample of ninety-six patients suffering from COPD (GOLD III/IV). Results of the MANOVA showed higher COPD-specific anxiety in patients with depressive symptoms than in patients without depressive symptoms. Depressive patients showed a higher fear of social isolation, dyspnea related fear, fear of movement and fear of progression of disease. There were no differences between the two groups with regard to functional parameters (FEV ₁ % pred.; 6-minute-walk-test). Overall, our study shows the necessity of the assessment of COPD-specific fears related to depression to guarantee an adequate treatment.

• Literatur

• 1 WHO. World Health Statistics 2008. Geneva: 2008
• 2 Buist AS, McBurnie MA, Vollmer WM et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-750
• 3 The Asia Pacific COPD Roundtable Group. Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: an Asia-Pacific perspective. Respirology 2005; 10: 9-17
• 4 Rutten-van Molken MP, Oostenbrink JB, Tashkin DP et al. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?. Chest 2006; 130: 1117-1128
• 5 Hill K, Geist R, Goldstein RS et al. Anxiety and depression in end-stage COPD. Eur Respir J 2008; 31: 667-677
• 6 Maurer J, Rebbapragada V, Borson S et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 2008; 134: 43-56
• 7 Di Marco F, Verga M, Reggente M et al. Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med 2006; 100: 1767-1774
• 8 van Manen JG, Bindels PJ, Dekker FW et al. The influence of COPD on health-related quality of life independent of the influence of comorbidity. J Clin Epidemiol 2003; 56: 1177-1184
• 9 Kühl K, Schürmann W, Rief W. Mental disorders and quality of life in COPD patients and their spouses. Int J Chron Obstruct Pulmon Dis 2008; 3: 727-736
• 10 Reuter K, Härter M. Diagnostik psychischer Belastungen und Störungen bei körperlichen Erkrankungen. In: Härter M, Baumeister H, Bengel J, Hrsg. Psychische Störungen bei körperlichen Erkrankungen. Berlin: Springer; 2007: 15-28
• 11 van Manen JG, Bindels PJ, Dekker FW et al. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 2002; 57: 412-416
• 12 WHO. International Classification of Diseases (10th revision). Genf: 1992
• 13 Eifert GH. Cardiophobia: a paradigmatic behavioural model of heart-focused anxiety and non-anginal chest pain. Behav Res Ther 1992; 30: 329-345
• 14 Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry 2000; 15: 1090-1096
• 15 Härter MC. Mental illness and physical disorders. Psychother Psychosom Med Psychol 2000; 50: 274-286
• 16 Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 2007; 29: 147-155
• 17 Herschbach P, Keller M, Knight L et al. Psychological problems of cancer patients: a cancer distress screening with a cancer-specific questionnaire. Br J Cancer 2004; 91: 504-511
• 18 Dankert A, Duran G, Engst-Hastreiter U et al. Progredienzangst bei Patienten mit Tumorerkrankungen, Diabetes mellitus und entzündlichen Erkrankungen des Bewegungsapperatestischen Erkrankungen. Rehabilitation 2003; 42: 155-163
• 19 Kühl K, Kuhn C, Kenn K et al. [The COPD-Anxiety-Questionnaire (CAF): a new instrument to assess illness specific anxiety in COPD patients]. Psychother Psychosom Med Psychol 2011; 61: e1-9
• 20 Livermore N, Butler JE, Sharpe L et al. Panic attacks and perception of inspiratory resistive loads in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 178: 7-12
• 21 Livermore N, Sharpe L, McKenzie D. Panic attacks and panic disorder in chronic obstructive pulmonary disease: a cognitive behavioral perspective. Respir Med 2010; 104: 1246-1253
• 22 Borak J, Sliwinski P, Piasecki Z et al. Psychological status of COPD patients on long term oxygen therapy. Eur Respir J 1991; 4: 59-62
• 23 Engström CP, Persson LO, Larsson S et al. Functional status and well being in chronic obstructive pulmonary disease with regard to clinical parameters and smoking: a descriptive and comparative study. Thorax 1996; 51: 825-830
• 24 Eisner MD, Blanc PD, Yelin EH et al. Influence of anxiety on health outcomes in COPD. Thorax 2010; 65: 229-234
• 25 Aydin IO, Ulusahin A. Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12. Gen Hosp Psychiatry 2001; 23: 77-83
• 26 Simon NM, Weiss AM, Kradin R et al. The relationship of anxiety disorders, anxiety sensitivity and pulmonary dysfunction with dyspnea-related distress and avoidance. J Nerv Ment Dis 2006; 194: 951-957
• 27 Kim HF, Kunik ME, Molinari VA et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics 2000; 41: 465-471
• 28 Gudmundsson G, Gislason T, Janson C et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J 2005; 26: 414-419
• 29 Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med 2003; 65: 963-970
• 30 Vögele C, von Leupoldt A. Mental disorders in chronic obstructive pulmonary disease (COPD). Respir Med 2008; 102: 764-773
• 31 Hynninen KM, Breitve MH, Wiborg AB et al. Psychological characteristics of patients with chronic obstructive pulmonary disease: a review. J Psychosom Res 2005; 59: 429-443
• 32 Eke M, McNally RJ. Anxiety sensitivity, suffocation fear, trait anxiety, and breath-holding duration as predictors of response to carbon dioxide challenge. Behav Res Ther 1996; 34: 603-607
• 33 McCathie HC, Spence SH, Tate RL. Adjustment to chronic obstructive pulmonary disease: the importance of psychological factors. Eur Respir J 2002; 19: 47-53
• 34 Barnett M. Chronic obstructive pulmonary disease: a phenomenological study of patients' experiences. J Clin Nurs 2005; 14: 805-812
• 35 Kanervisto M, Paavilainen E, Astedt-Kurki P. Impact of chronic obstructive pulmonary disease on family functioning. Heart Lung 2003; 32: 360-367
• 36 Kanervisto M, Paavilainen E, Heikkila J. Family dynamics in families of severe COPD patients. J Clin Nurs 2007; 16: 1498-1505
• 37 Mikkelsen RL, Middelboe T, Pisinger C et al. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry 2004; 58: 65-70
• 38 Ng TP, Niti M, Tan WC et al. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007; 167: 60-67
• 39 Garrod R, Marshall J, Barley E et al. Predictors of success and failure in pulmonary rehabilitation. Eur Respir J 2006; 27: 788-794
• 40 Yeh ML, Chen HH, Liao YC et al. Testing the functional status model in patients with chronic obstructive pulmonary disease. J Adv Nurs 2004; 48: 342-350
• 41 Felker B, Katon W, Hedrick SC et al. The association between depressive symptoms and health status in patients with chronic pulmonary disease. Gen Hosp Psychiatry 2001; 23: 56-61
• 42 Snaith RP, Zigmond AS. The hospital anxiety and depression scale. Br Med J (Clin Res Ed) 1986; 292: 344
• 43 Chambless DL, Caputo GC, Bright P et al. Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire. J Consult Clin Psychol 1984; 52: 1090-1097
• 44 Hien P, Morr H. Six-minute walk test in chronic lung and heart disease - technical aspects, interpretation, limitations. Pneumologie 2002; 56: 558-566
• 45 Berg P, Book K, Dinkel A et al. Fear of progression in chronic diseases. Psychother Psychosom Med Psychol 2011; 61: 32-37
• 46 Uhlemann C. Wie die Lunge die Lebenskraft bestimmt. Forsch Komplementärmed 2007; 14: 173-179
• 47 Vogelmeier C, Buhl R, Criée CP et al. Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga und Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin. Pneumologie 2007; 61: e1-40
• 48 Worth H, Meyer A, Folgering H et al. Recommendations of the German Respiratory League on sports and physical training for patients with obstructive respiratory tract diseases. Pneumologie 2000; 54: 61-67
• 49 Leeuw M, Goossens ME, Linton SJ et al. The fear-avoidance model of musculoskeletal pain: current state of scientific evidence. J Behav Med 2007; 30: 77-94
• 50 Vlaeyen JW, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain 2000; 85: 317-332
• 51 Andenaes R, Kalfoss MH, Wahl AK. Coping and psychological distress in hospitalized patients with chronic obstructive pulmonary disease. Heart Lung 2006; 35: 46-57
• 52 Engst-Hastreiter U, Duran G, Henrich G et al. Progredienzangst (PA) bei chronischen Erkrankungen (Rheumatischen Erkrankungen, Krebserkrankungen und Diabetes mellitus). Akt Rheumatol 2004; 29: 83-91
• 53 Singer S, Kuhnt S, Gotze H et al. Hospital anxiety and depression scale cutoff scores for cancer patients in acute care. Br J Cancer 2009; 100: 908-912
• 54 Olsson I, Mykletun A, Dahl AA. The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 2005; 5: 46
• 55 Herrmann C, Brand-Driehorst S, Buss U et al. Effects of anxiety and depression on 5-year mortality in 5,057 patients referred for exercise testing. J Psychosom Res 2000; 48: 455-462